Treatments for Moderate hemophilia B
FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.
ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing dataFDA-approved treatments (5)
- AlhemoCONCIZUMABNovo NordiskApproved Jul 2025
- QfitliaFITUSIRANGenzyme CorporationApproved Mar 2025
- Beqvezfidanacogene elaparvovec-dzktPfizer Inc.Approved Apr 2024
- HEMGENIXETRANACOGENE DEZAPARVOVECCSL BehringApproved Nov 2022
- Idelvionrecombinant fusion protein linking coagulation factor IX with albumin (rIX-FP)CSL Behring, LLCApproved Mar 2016
Patient support programs (3)
Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.
Beqvez
Pfizer Inc.
Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications
Idelvion
CSL Behring, LLC
Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications
Alhemo
Novo Nordisk
Alhemo Patient Support (NovoCare)
Patient Assistance
Manufacturer Program
Accepting applications